Rapamycin unbalances the polarization of human macrophages to M1
Top Cited Papers
- 12 September 2013
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 140 (2), 179-190
- https://doi.org/10.1111/imm.12126
Abstract
Plasticity is a hallmark of macrophages, and in response to environmental signals these cells undergo different forms of polarized activation, the extremes of which are called classic (M1) and alternative (M2). Rapamycin (RAPA) is crucial for survival and functions of myeloid phagocytes, but its effects on macrophage polarization are not yet studied. To address this issue, human macrophages obtained from six normal blood donors were polarized to M1 or M2 in vitro by lipopolysaccharide plus interferon-gamma or interleukin-4 (IL-4), respectively. The presence of RAPA (10ng/ml) induced macrophage apoptosis in M2 but not in M1. Beyond the impact on survival in M2, RAPA reduced CXCR4, CD206 and CD209 expression and stem cell growth factor-beta, CCL18 and CCL13 release. In contrast, in M1 RAPA increased CD86 and CCR7 expression and IL-6, tumour necrosis factor-alpha and IL-1 beta release but reduced CD206 and CD209 expression and IL-10, vascular endothelial growth factor and CCL18 release. In view of the in vitro data, we examined the in vivo effect of RAPA monotherapy (0 center dot 1mg/kg/day) in 12 patients who were treated for at least 1month before islet transplant. Cytokine release by Toll-like receptor 4-stimulated peripheral blood mononuclear cells showed a clear shift to an M1-like profile. Moreover, macrophage polarization 21days after treatment showed a significant quantitative shift to M1. These results suggest a role of mammalian target of rapamycin (mTOR) into the molecular mechanisms of macrophage polarization and propose new therapeutic strategies for human M2-related diseases through mTOR inhibitor treatment.Keywords
This publication has 54 references indexed in Scilit:
- Distribution of macrophage polarization markers in human atherosclerosisAtherosclerosis, 2012
- Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-α expression in macrophages by reducing IL-10 expressionMolecular Immunology, 2009
- Immunoregulatory functions of mTOR inhibitionNature Reviews Immunology, 2009
- The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory ResponseImmunity, 2008
- Rapamycin Monotherapy in Patients With Type 1 Diabetes Modifies CD4+CD25+FOXP3+ Regulatory T-CellsDiabetes, 2008
- Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathwayNature Immunology, 2008
- Macrophage Polarization Comes of AgeImmunity, 2005
- Rapamycin-Treated, Alloantigen-Pulsed Host Dendritic Cells Induce Ag-Specific T Cell Regulation and Prolong Graft SurvivalAmerican Journal of Transplantation, 2005
- Contrasting Impacts of Immunosuppressive Agents (Rapamycin, FK506, Cyclosporin A, and Dexamethasone) on Bidirectional Dendritic Cell-T Cell Interaction During Antigen PresentationThe Journal of Immunology, 2002
- Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophagesBlood, 2001